InProTher
About:
InProTher is an immuno therapy company dedicated to developing the world’s first adaptive immune therapy.
Website: https://www.inprother.com/
Top Investors: European Innovation Council, SeedFolio
Description:
InProTher is an immunotherapy company dedicated to developing the world’s first adaptive immune therapy capable of targeting immunosuppressive genes of ancient retroviruses.
Total Funding Amount:
8.5M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Copenhagen, Hovedstaden, Denmark
Founded Date:
2018-01-01
Contact Email:
contact(AT)inprother.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-05-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai